Testing effectiveness (Phase 2)Study completedNCT00412880What this trial is testingBI 2536 Second Line Monotherapy in SCLCWho this might be right forCarcinoma, Small Cell Boehringer Ingelheim 23
Post-approval studies (Phase 4)Study completedNCT05110196What this trial is testingStudy of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.Who this might be right forNon-Small Cell Lung Carcinoma Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Looking for participantsNCT05797168What this trial is testingPhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid TumorsWho this might be right forOvarian CancerLung AdenocarcinomaEndometrial Cancer+1 more AstraZeneca 602
Not applicableStudy completedNCT04732520What this trial is testingFeasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Galvanize Therapeutics, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03371979What this trial is testingPegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung CancerWho this might be right forSmall-cell Lung Cancer Aeglea Biotherapeutics 68
Testing effectiveness (Phase 2)UnknownNCT05228496What this trial is testingInvestigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLCWho this might be right forLung Cancer, Small Cell Zhejiang Cancer Hospital 21
Not applicableLooking for participantsNCT06494540What this trial is testingNIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic AlterationsWho this might be right forNon-squamous Metastatic Non-Small-Cell Lung Carcinoma AstraZeneca 600
Testing effectiveness (Phase 2)Looking for participantsNCT07120282What this trial is testingStudy to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLCWho this might be right forLung Cancer (NSCLC) Cancer Institute and Hospital, Chinese Academy of Medical Sciences 108
Large-scale testing (Phase 3)Study completedNCT01040780What this trial is testingSafety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) PatientsWho this might be right forNon-small Cell Lung Cancer Betta Pharmaceuticals Co., Ltd. 399
Testing effectiveness (Phase 2)Active Not RecruitingNCT02716116What this trial is testingTAK-788 in Adults With Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Takeda 334
Early research (Phase 1)Study completedNCT04069026What this trial is testingA First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced CancerWho this might be right forAdvanced Solid Tumors Bayer 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06882174What this trial is testingThis Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung CancerWho this might be right forMetastatic Non Small Cell Lung Cancer AHS Cancer Control Alberta 58
Large-scale testing (Phase 3)Ended earlyNCT00054210What this trial is testingPolyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer CTI BioPharma
Large-scale testing (Phase 3)UnknownNCT04964479What this trial is testingA Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)Who this might be right forNon Small Cell Lung Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 375
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796089What this trial is testingChemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic RadiotherapyWho this might be right forExtensive-Stage Small-Cell Lung Cancer Trans Tasman Radiation Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT00098085What this trial is testingStudy of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung CarcinomaLung CancerPulmonary Cancer Agenus Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT00321308What this trial is testingTrial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small Cell Lung Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT01259089What this trial is testingHsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungNon-small Cell Lung Cancer Northwestern University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06918132What this trial is testingCemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more Mayo Clinic 60
Testing effectiveness (Phase 2)WithdrawnNCT04576208What this trial is testingEvaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788Who this might be right forNon-Small Cell Lung Cancer (NSCLC) Takeda